Stocks and Investing Stocks and Investing
Thu, March 12, 2020
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (SPGI) at Buy with Decreased Target to $319 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (SO) at Sell with Decreased Target to $59 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Mark Murphy Maintained (WDAY) at Buy with Decreased Target to $175 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Eric Beaumont Downgraded (WEC) to Sell and Increased Target to $97 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Amit Mehrotra Maintained (WERN) at Strong Buy with Decreased Target to $38 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Philip Gibbs Maintained (ATI) at Buy with Decreased Target to $18 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (ATO) at Buy with Decreased Target to $110 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Paul Matteis Initiated (AVDL) at Strong Buy and Held Target at $14 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Mark Weintraub Maintained (BLFS) at Strong Buy with Decreased Target to $24 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Mark Mahaney Upgraded (TREE) to Buy and Decreased Target to $332 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
JR Weston Downgraded (TRGP) to Buy on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Adam Jonas Maintained (TSLA) at Sell with Decreased Target to $32 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Rob Oliver Maintained (TYL) at Hold with Decreased Target to $320 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Jim Kelleher Upgraded (SWKS) to Strong Buy and Held Target at $112 on, Mar 12th, 2020
[ 12:00 AM ] - WOPRAI
Katy Huberty Maintained (STX) at Buy with Decreased Target to $60 on, Mar 12th, 2020
Wed, March 11, 2020
[ 12:00 AM ] - WOPRAI
Aaron Rakers Maintained (STX) at Hold with Decreased Target to $52 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
John Staszak Downgraded (UAL) to Hold on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Michael Turrin Maintained (TWLO) at Buy with Decreased Target to $140 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Paul Coster Downgraded (TTMI) to Hold and Decreased Target to $15 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Thomas Curran Downgraded (TTI) to Hold and Decreased Target to $1.25 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Edward Shields Maintained (TRV) at Hold with Decreased Target to $125 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Ashish Sabadra Maintained (TRU) at Strong Buy with Decreased Target to $93 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Lloyd Walmsley Maintained (BKNG) at Strong Buy on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Anthony Pettinari Maintained (AVY) at Hold with Decreased Target to $124 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Jonathan Reeder Upgraded (AWR) to Hold and Held Target at $84 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Christopher Glynn Maintained (WCC) at Buy with Decreased Target to $64 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Justin Long Maintained (WAB) at Buy with Decreased Target to $80 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Keyur Parekh Upgraded (SNY) to Strong Buy on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
Richard Hill Maintained (SPG) at Hold with Decreased Target to $120 on, Mar 11th, 2020
[ 12:00 AM ] - WOPRAI
David Lebowitz Maintained (SNDX) at Hold with Increased Target to $10 on, Mar 11th, 2020

David Lebowitz Maintained (SNDX) at Hold with Increased Target to $10 on, Mar 11th, 2020


Published on 2024-10-26 23:37:08 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Increased Target from $8 to $10 on, Mar 11th, 2020.

David has made no other calls on SNDX in the last 4 months.



There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David

  • Peter Lawson of "Barclays" Initiated at Buy and Held Target at $15 on, Wednesday, March 4th, 2020
  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $17 on, Monday, January 13th, 2020
Contributing Sources